We are live on
!
Find out more
HF
HRT Financial Portfolio holdings
AUM
$40.1B
1-Year Est. Return
58.22%
This Fund
S&P 500
This Quarter
Est. Return
+7.61%
1 Year Est. Return
+58.22%
3 Year Est. Return
+133.11%
5 Year Est. Return
+158.39%
10 Year Est. Return
+582.8%
AUM
$10.9B
AUM Growth
+$1.02B
(+10%)
Cap. Flow
+$745M
Cap. Flow
% of AUM
6.83%
Top 10 Holdings %
Top 10 Hldgs %
30.62%
Holding
3,895
New
1,275
Increased
568
Reduced
596
Closed
1,134
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$289M |
| 2 |
Linde
LIN
|
+$254M |
| 3 |
GRUB
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
|
+$244M |
| 4 |
Moderna
MRNA
|
+$104M |
| 5 |
Honeywell
HON
|
+$96.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$330M |
| 2 |
ExxonMobil
XOM
|
+$206M |
| 3 |
Palantir
PLTR
|
+$130M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$97.8M |
| 5 |
Snowflake
SNOW
|
+$81.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.66% |
| 2 | Healthcare | 9.21% |
| 3 | Consumer Discretionary | 8.28% |
| 4 | Industrials | 6.28% |
| 5 | Materials | 5.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMED
376
DELISTED
Amedisys
AMED
| $3.9M | 0.04% |
15,941
+9,829
| +161% | +$2.58M |
|
377
Wolverine World Wide
WWW
$1.61B
| $3.9M | 0.04% |
+115,905
| New | +$4.39M |
|
|
HOLX
378
DELISTED
Hologic
HOLX
| $3.87M | 0.04% |
+57,937
| New | +$3.87M |
|
379
Diageo
DEO
$49B
| $3.86M | 0.04% |
20,133
+4,564
| +29% | +$849K |
|
|
TMHC
380
DELISTED
Taylor Morrison
TMHC
| $3.86M | 0.04% |
+145,962
| New | +$4.34M |
|
381
Ubiquiti
UI
$33.7B
| $3.84M | 0.04% |
+12,300
| New | +$3.6M |
|
382
MSC Industrial Direct
MSM
$6.89B
| $3.79M | 0.03% |
+42,302
| New | +$3.87M |
|
383
CALL
Advanced Micro Devices
AMD
$776B
| $3.75M | 0.03% |
39,900
-167,700
| -81% | -$13.6M |
|
|
VERV
384
DELISTED
Verve Therapeutics
VERV
| $3.75M | 0.03% |
+62,159
| New | +$2.58M |
|
385
Elanco Animal Health
ELAN
$13.2B
| $3.74M | 0.03% |
+107,812
| New | +$3.56M |
|
386
Keurig Dr Pepper
KDP
$42.3B
| $3.73M | 0.03% |
+105,874
| New | +$3.78M |
|
387
ProShares UltraPro Short QQQ
SQQQ
$2.04B
| $3.73M | 0.03% |
3,260
-1,660
| -34% | -$2.28M |
|
388
Amcor
AMCR
$20.8B
| $3.72M | 0.03% |
64,909
-99,728
| -61% | -$5.93M |
|
|
FITB
389
Fifth Third Bancorp
FITB
$51.2B
| $3.68M | 0.03% |
96,223
-630,149
| -87% | -$25.2M |
|
390
Manhattan Associates
MANH
$11.2B
| $3.68M | 0.03% |
+25,380
| New | +$3.38M |
|
391
Owens Corning
OC
$11.2B
| $3.67M | 0.03% |
+37,531
| New | +$3.75M |
|
392
iShares US Financials ETF
IYF
$4.67B
| $3.66M | 0.03% |
+45,151
| New | +$3.63M |
|
393
VanEck Oil Services ETF
OIH
$2.06B
| $3.65M | 0.03% |
16,677
-33,213
| -67% | -$6.94M |
|
394
Grand Canyon Education
LOPE
$3.79B
| $3.65M | 0.03% |
+40,528
| New | +$4.01M |
|
|
SCS
395
DELISTED
Steelcase
SCS
| $3.63M | 0.03% |
+240,181
| New | +$3.46M |
|
396
State Street SPDR S&P Dividend ETF
SDY
$21.7B
| $3.58M | 0.03% |
29,316
-31,923
| -52% | -$3.95M |
|
397
Franklin Resources
BEN
$17.6B
| $3.52M | 0.03% |
110,140
+15,871
| +17% | +$514K |
|
|
SNBR
398
DELISTED
Sleep Number
SNBR
| $3.52M | 0.03% |
32,015
-11,048
| -26% | -$1.26M |
|
399
CALL
Nike
NKE
$61.9B
| $3.51M | 0.03% |
22,700
-35,700
| -61% | -$4.8M |
|
400
Brown-Forman Class B
BF.B
$13.2B
| $3.5M | 0.03% |
+46,775
| New | +$3.56M |
|
Similar funds
HRT Financial's Q2 2021 Portfolio in Review
As of Q2 2021, HRT Financial held 3,895 positions worth $10.9B, up 10% from $9.88B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
HRT Financial deployed $745M of net new capital in Q2 2021, opening 1,275 new positions and adding to 568 existing holdings. Its largest new stake was Linde: 872,603 shares worth $252M.
By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 8.1% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $330M trimmed.
- HRT Financial's largest Q2 2021 buy was Linde: 872,603 shares worth $252M.
- HRT Financial added most to Invesco QQQ Trust in Q2 2021, an estimated $289M increase.
- HRT Financial's biggest Q2 2021 reduction was iShares Russell 2000 ETF, cutting an estimated $330M.
- HRT Financial fully exited Palantir in Q2 2021, selling an estimated $130M.
- HRT Financial's ten largest holdings make up 31% of its $10.9B portfolio in Q2 2021.
- HRT Financial opened 1,275 new positions and closed 1,134 in Q2 2021.
- HRT Financial's portfolio value rose 10% quarter-over-quarter to $10.9B.
Based on HRT Financial's 13F filing for Q2 2021, filed 16 Aug 2021.